Background: Allergy to tree pollen is common and aeroallergens have been associated with severe asthma exacerbations in the community setting. To determine the impact of different trees on asthma, we tested the association between daily hospitalizations for asthma and daily concentrations of different tree pollens in 10 large Canadian cities. Methods: Daily time-series analyses were employed to remove unwanted temporal trends. For each family or genus, results were adjusted for day of the week, temperature, barometric pressure and relative humidity. Results were expressed as the percentage increase in asthma hospitalizations related to an increase in tree pollen concentration equivalent in magnitude to its interquartile range. Results: For an interquartile increase in daily tree pollen concentration, percent increases in daily hospitalization for asthma were: 2.63% (95% CI 1.19–4.07) for Ulmus (elm), 2.45% (1.12–3.78) for the group containing Pinaceae (pine, fir, spruce), Tsuga (hemlock) and Larix (larch, tamarack); 2.32% (0.93–3.71) for the group containing Quercus (oak) and Castanea (chestnut), and 2.16% (0.70–3.62) for Acer (boxelder and maple). Statistically significant (p < 0.05) but small (<2%) effects were observed for Fraxinus (ash), Populus (aspen, poplar), Alnus (alder), Betula (birch) and Corylus (hazelnut). Conclusions: Several common tree pollens are an important cause of acute exacerbations of asthma severe enough to require hospitalization.

1.
Bass DJ, Delpech V, Beard J, Bass P, Walls RS: Ragweed in Australia. Aerobiologia 2000;16:107–111.
2.
Bass DJ, Delpech V, Beard J, Bass P, Walls RS: Late summer and fall (March-May) pollen allergy and respiratory disease in Northern New South Wales, Australia. Ann Allergy Asthma Immunol 2000;85:374–381.
3.
Bist A, Singh AB, Kumar L, Roy I, Ravindran P, Gaur SN: Clinico-immunologic evaluation of allergy to Himalayan tree pollen in atopic subjects in India – a new record. Asian Pac J Allergy Immunol 2005;23:69–78.
4.
Celik G, Mungan D, Pinar M, Misirligil Z: Poplar pollen-related allergy in Ankara, Turkey: how important for patients living in a city with high pollen load? Allergy Asthma Proc 2005;26:113–119.
5.
Deane P: Conifer pollen sensitivity in western New York: cedar pollens. Allergy Asthma Proc 2005;26:352–355.
6.
Lewis SA, Corden JM, Forster GE, Newlands M: Combined effects of aerobiological pollutants, chemical pollutants and meteorological conditions on asthma admissions and A & E attendances in Derbyshire UK, 1993–96. Clin Exp Allergy 2000;30:1724–1732.
7.
Lierl MB, Hornung RW: Relationship of outdoor air quality to pediatric asthma exacerbations. Ann Allergy Asthma Immunol 2003;90:28–33.
8.
Dales R, Cakmak S, Burnett R, Judek S, Coates F, Brook J: Influence of ambient fungal spore on emergency visits for asthma to a regional children’s hospital. Am J Crit Care Med 2000;162:2087–2090.
9.
Tobias A, Galan A, Banegas J: Non-linear short-term effects of airborne pollen levels with allergenic capacity on asthma emergency room admissions in Madrid, Spain. Clin Exp Allergy 2004;34:871.
10.
O’Hollaren MT, Yunginger JW, Offord KP, Somers MJ, O’Connell EJ, Ballard DJ, Sachs MI: Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. N Engl J Med 1991;324:359–363.
11.
Salvaggio J, Seabury J, Schoenhardt EA: New Orleans asthma. 5. Relationship between Charity Hospital asthma admission rates, semiquantitative pollen and fungal spore counts, and total particulate aerometric sampling data. J Allergy Clin Immunol 1971;48:96–114.
12.
Targonski PV, Persky VW, Ramekrishnan V: Respiratory pathophysiologic responses. Effect of environmental molds on risk of death from asthma during the pollen season. J Allergy Clin Immunol 1995;95:955–961.
13.
Dales RE, Cakmak S, Judek S, Dann T, Coates F, Burnett RT: Influence of outdoor aeroallergens on hospitalization for asthma in Canada. J Allergy Clin Immunol 2004;113:303–306.
14.
Delfino RJ, Murphy-Moulton AM, Burnett RT, Brook JR, Becklake MR: Effects of air pollution on emergency room visits for respiratory illnesses in Montreal, Quebec. Am J Respir Crit Care Med 1997;155:568–576.
15.
Epton MJ, Martin IR, Graham P, Healy PE, Smith H, Balasubramaniam R, Harvey IC, Fountain DW, Hedley J, Town GI: Climate and aeroallergen levels in asthma: a 12 month prospective study. Thorax 1997;52:528–534.
16.
de Hoog GS, Guarro J, Gene J, Figueras MJ: Atlas in Clinical Fungi, ed 2. Utrecht, Centraalbureau voor Schimmelcultures/Universitat Rovira i Virgili, 2000, pp 1–1126.
17.
Lindstrom ML, Bates DM: Nonlinear mixed effects models for repeated measures data. Biometrics 1990;46:673–687.
18.
Hoek G, Schwartz JD, Gros R, Eilers P: Effects of ambient particulate matter and ozone on daily mortality in Rotterdam, The Netherlands. J Arch Environ Health 1997;52:455–463.
19.
Akaike H: A new look at the statistical model identification. IEEE Trans Automatic Control 1974;19:716–722.
20.
Priestly MB: Spectral Analysis of Time Series. San Diego, Academic Press, 1981.
21.
Hastie T, Tibshirani R: Generalized Additive Models. London, Chapman and Hall, 1990.
22.
Platts-Mills T: Major risk factors according to age: the relevance of indoor allergens to the increase in asthma; in Neffen HE, Boena-Cagnani CE, Habbri L, Holgate S, O’Bryne TO (eds): Asthma – A Link between Environment, Immunology and the Airways. Seattle, Hogrefe & Huber Publishers, 1999.
23.
Filon F, Bosco A, Barbina P, Sauli ML, Longobardo GS: Betulaceae and Corylaceae in Trieste (Ne-Italy): aerobiological and clinical data. Aerobiologia 2000;16:87–91.
24.
Lin RY, Clauss AE, Bennett ES: Hypersensitivity to common tree pollen in New York City patients. Allergy Asthma Proc 2002;23:253–258.
25.
White JF, Bernstein D: Key pollen allergens in North America. Ann Allergy Asthma Immunol 2003;91:425–435.
26.
Schappi GF, Taylor PE, Staff IA, Rolland JM, Suphioglu C: Immunologic significance of respirable atmospheric starch granules containing major birch allergen Bet v 1. Allergy 1999;54:478–483.
27.
Schappi GF, Taylor PE, Pain MC, Cameron PA, Dent AW, Staff IA, Suphioglu C: Concentrations of major grass group 5 allergens in pollen grains and atmospheric particles: implications for hay fever and allergic asthma sufferers sensitized to grass pollen allergens. Clin Exp Allergy 1999;29:633–641.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.